Financial reports
10-Q
2016 Q3
Quarterly report
14 Nov 16
10-Q
2016 Q2
Quarterly report
22 Aug 16
NT 10-Q
Notice of late quarterly filing
16 Aug 16
10-Q
2016 Q1
Quarterly report
16 May 16
10-K
2015 FY
Annual report
30 Mar 16
10-Q
2015 Q3
Quarterly report
16 Nov 15
10-Q
2015 Q2
Quarterly report
14 Aug 15
10-Q
2015 Q1
Quarterly report
15 May 15
10-K
2014 FY
Annual report
31 Mar 15
10-Q
2014 Q3
Quarterly report
14 Nov 14
Current reports
8-K
Entry into a Material Definitive Agreement
16 Aug 16
8-K
Departure of Directors or Certain Officers
17 Mar 16
8-K
Entry into a Material Definitive Agreement
13 Jan 16
8-K
Entry into a Material Definitive Agreement
26 Oct 15
8-K
Departure of Directors or Certain Officers
11 Sep 15
8-K
Other Events
31 Dec 14
8-K
Departure of Directors or Certain Officers
4 Dec 14
8-K
Other Events
28 Oct 14
8-K
Departure of Directors or Certain Officers
31 Jul 14
8-K
Arno Therapeutics, Inc. Appoints Alexander Zukiwski, M.D. as Interim Chief Executive Officer and Mr. Lawrence Kenyon as Chief Operating Officer
23 Jul 14
Registration and prospectus
15-12G
Securities registration termination
30 Mar 17
POS AM
Prospectus update (post-effective amendment)
28 Mar 17
POS AM
Prospectus update (post-effective amendment)
28 Mar 17
S-8 POS
Registration of securities for employees (post-effective amendment)
28 Mar 17
424B3
Prospectus supplement
4 Nov 16
S-1
IPO registration
12 Oct 16
D
$4.51M in equity / options / securities to be acquired, sold $4.51M, 15 investors
30 Aug 16
424B3
Prospectus supplement
19 Apr 16
S-1/A
IPO registration (amended)
1 Apr 16
S-1
IPO registration
11 Mar 16
Other
EFFECT
Notice of effectiveness
31 Mar 17
EFFECT
Notice of effectiveness
31 Mar 17
EFFECT
Notice of effectiveness
3 Nov 16
CORRESP
Correspondence with SEC
31 Oct 16
UPLOAD
Letter from SEC
24 Oct 16
EFFECT
Notice of effectiveness
18 Apr 16
CORRESP
Correspondence with SEC
14 Apr 16
UPLOAD
Letter from SEC
29 Mar 16
CT ORDER
Confidential treatment order
24 Mar 16
CT ORDER
Confidential treatment order
7 Aug 14
Ownership
SC 13G/A
Arno Therapeutics, Inc
3 Jan 18
SC 13G/A
Arno Therapeutics, Inc
14 Feb 17
SC 13G/A
Arno Therapeutics, Inc
14 Feb 17
SC 13G/A
Arno Therapeutics, Inc
14 Feb 17
3
Jonathan J Zucker
9 Jan 17
SC 13D
Arno Therapeutics, Inc
9 Jan 17
SC 13G/A
Arno Therapeutics, Inc
5 Jan 17
4
S DONALD SUSSMAN
3 Jan 17
SC 13D/A
Arno Therapeutics, Inc
3 Jan 17
4
DAVID M TANEN
5 Oct 16